Milken Institute 8d ago

Watch all 2026 Global Conference session replays: https://milkeninstitute.org/events/global-conference-2026/program Scientific and technological advances are transforming our understanding of health, aging, and human biology in ways unthinkable just a decade ago. Regeneration, rejuvenation, peptides, reprogramming, and AI-enabled precision health now shape the longevity narrative, championed by voices ranging from fringe biohackers to wellness influencers to world-class physicians and scientists. Yet, this expansion of approaches, claims, and products has made it difficult for markets and consumers to discern what is ready for broad application from what is still emerging. New speculative interventions can also take the focus away from those proven to extend healthy life. As capital flows into the longevity space, how can markets distinguish promise from hype and translate credible science into investable, scalable solutions—while also clarifying what individuals can safely apply today? Richard Lui Anchor, MSNOW; Principal, CAREGenome; Chief Impact Officer, Caregiving Moonshot Joe Betts-LaCroix Founder and CEO, Retro Biosciences Tom Hale CEO, Oura Health Richard Isaacson Director, Atria Precision Prevention Program Carina Kern CEO and Founder, LinkGevity John Whyte CEO, American Medical Association